Dawson James Securities Initiates Research Coverage of StemCells, Inc. With Buy Recommendation.
Business Wire › January 14, 2009
Linked as:
Extract
Dawson James Securities Initiates Research Coverage of StemCells, Inc. With Buy Recommendation.
PALO ALTO, Calif. -- StemCells, Inc. (NASDAQ:STEM) today announced that Dawson James Securities, Inc. has initiated research coverage on the Company with a "speculative buy" rating and a target price of $3....
See the full content of this document
Sponsored links
